Shingo Hatakeyama

About Shingo Hatakeyama

Shingo Hatakeyama, With an exceptional h-index of 37 and a recent h-index of 28 (since 2020), a distinguished researcher at Hirosaki University, specializes in the field of Urology, Kidney Transplantation, Oncology, Dialysis.

His recent articles reflect a diverse array of research interests and contributions to the field:

Summary of the clinical practice guidelines for upper tract urothelial carcinoma 2023 by the Japanese Urological Association

Real-world effects of novel androgen receptor axis-targeted agents on oncological outcomes in non-metastatic castration-resistant prostate cancer: A multi-institutional …

MP14-14 THE IMPACT OF DELAYED ADMINISTRATION OF ANDROGEN-RECEPTOR SIGNALING INHIBITORS (ARSI) ON PROGNOSIS FOR MHNPC

MP66-18 ASSOCIATION BETWEEN AORTIC CALCIFICATION BURDEN AND ERECTILE DYSFUNCTION SEVERITY IN MEN UNDERGOING DIALYSIS: A CROSS-SECTIONAL STUDY

Prognostic impact of histological discordance between transurethral resection and radical cystectomy

MP69-10 ELEVATED PLASMA HYALURONAN LEVELS IS A RISK FACTOR FOR MAJOR ADVERSE CARDIOVASCULAR EVENTS IN UROLOGICAL SEPSIS

MP14-05 THE IMPACT OF UPFRONT COMBINATION THERAPY IN PATIENTS WITH MCSPC ON OS AFTER MCRPC: A MULTICENTRE RETROSPECTIVE STUDY

Incidence of postoperative cytomegalovirus and BK-polyoma virus infections and graft loss in ABO-incompatible renal transplant recipients: a multicenter retrospective study

Shingo Hatakeyama Information

University

Position

School of Medicine

Citations(all)

5766

Citations(since 2020)

3610

Cited By

3628

hIndex(all)

37

hIndex(since 2020)

28

i10Index(all)

165

i10Index(since 2020)

124

Email

University Profile Page

Google Scholar

Shingo Hatakeyama Skills & Research Interests

Urology

Kidney Transplantation

Oncology

Dialysis

Top articles of Shingo Hatakeyama

Summary of the clinical practice guidelines for upper tract urothelial carcinoma 2023 by the Japanese Urological Association

2024/3

Real-world effects of novel androgen receptor axis-targeted agents on oncological outcomes in non-metastatic castration-resistant prostate cancer: A multi-institutional …

Prostate international

2024/3/1

Shingo Hatakeyama
Shingo Hatakeyama

H-Index: 25

MP14-14 THE IMPACT OF DELAYED ADMINISTRATION OF ANDROGEN-RECEPTOR SIGNALING INHIBITORS (ARSI) ON PROGNOSIS FOR MHNPC

The Journal of Urology

2024/5

Shingo Hatakeyama
Shingo Hatakeyama

H-Index: 25

MP66-18 ASSOCIATION BETWEEN AORTIC CALCIFICATION BURDEN AND ERECTILE DYSFUNCTION SEVERITY IN MEN UNDERGOING DIALYSIS: A CROSS-SECTIONAL STUDY

The Journal of Urology

2024/5

Shingo Hatakeyama
Shingo Hatakeyama

H-Index: 25

Prognostic impact of histological discordance between transurethral resection and radical cystectomy

BJU international

2024/2/12

MP69-10 ELEVATED PLASMA HYALURONAN LEVELS IS A RISK FACTOR FOR MAJOR ADVERSE CARDIOVASCULAR EVENTS IN UROLOGICAL SEPSIS

The Journal of Urology

2024/5

Hiroyuki Ito
Hiroyuki Ito

H-Index: 24

Shingo Hatakeyama
Shingo Hatakeyama

H-Index: 25

MP14-05 THE IMPACT OF UPFRONT COMBINATION THERAPY IN PATIENTS WITH MCSPC ON OS AFTER MCRPC: A MULTICENTRE RETROSPECTIVE STUDY

The Journal of Urology

2024/5

Shingo Hatakeyama
Shingo Hatakeyama

H-Index: 25

Incidence of postoperative cytomegalovirus and BK-polyoma virus infections and graft loss in ABO-incompatible renal transplant recipients: a multicenter retrospective study

International Urology and Nephrology

2024/2/9

Shingo Hatakeyama
Shingo Hatakeyama

H-Index: 25

PD38-06 EFFECT OF MAXIMAL TRANSURETHRAL RESECTION PRIOR TO NEOADJUVANT CHEMOTHERAPY ON ONCOLOGICAL OUTCOMES IN PATIENTS WHO UNDERGO RADICAL CYSTECTOMY: A MULTICENTER …

The Journal of Urology

2024/5

Hiroyuki Ito
Hiroyuki Ito

H-Index: 24

Shingo Hatakeyama
Shingo Hatakeyama

H-Index: 25

MP12-07 THE RELATIONSHIP BETWEEN FRAILTY AND INSTRUMENTAL ACTIVITIES OF DAILY LIVING AND ITS IMPACT ON QUALITY-OF-LIFE IN PATIENTS WITH UROLOGICAL CANCERS

The Journal of Urology

2024/5

Shingo Hatakeyama
Shingo Hatakeyama

H-Index: 25

Risk factors for neoadjuvant chemotherapy-induced acute kidney injury in patients with muscle-invasive bladder cancer: A multicenter retrospective study.

2024/2/1

Shingo Hatakeyama
Shingo Hatakeyama

H-Index: 25

PD63-09 ENDOTHELIAL GLYCOCALYX INJURY AS A RISK FACTOR FOR DISSEMINATED INTRAVASCULAR COAGULATION DEVELOPMENT IN UROLOGICAL SEPSIS

The Journal of Urology

2024/5

Shingo Hatakeyama
Shingo Hatakeyama

H-Index: 25

Effects of perioperative chemotherapy on prognosis in muscle invasive bladder cancer treated with radical cystectomy.

2024/2/1

MP22-04 EFFECTS OF RADIATION THERAPY TO THE RECURRENCE SITES ON ONCOLOGICAL OUTCOMES IN PATIENTS WHO EXPERIENCED LOCAL RECURRENCE AND/OR PELVIC LYMPH NODE METASTASES AFTER …

The Journal of Urology

2024/5

Hiroyuki Ito
Hiroyuki Ito

H-Index: 24

Shingo Hatakeyama
Shingo Hatakeyama

H-Index: 25

Association of perioperative acute kidney injury with oncological outcomes in patients who undergo radical cystectomy: A multicenter retrospective study.

2024/2/1

Shingo Hatakeyama
Shingo Hatakeyama

H-Index: 25

MP74-02 CHARACTERISTICS OF THE α2, 3-SIALYL N-GLYCOSYLATED PROSTATE-SPECIFIC ANTIGEN AS A BIOMARKER FOR PROSTATE CANCER IN MEN WITH GREY ZONE LEVELS OF THE PROSTATE-SPECIFIC …

The Journal of Urology

2024/5

Shingo Hatakeyama
Shingo Hatakeyama

H-Index: 25

MP69-09 ROLE OF SERUM IMMUNOGLOBULIN N-GLYCANS IN THE PROTECTION OF ENDOTHELIAL GLYCOCALYX IN UROLOGICAL SEPSIS

Journal of Urology

2024/5/1

Shingo Hatakeyama
Shingo Hatakeyama

H-Index: 25

Prognostic outcomes in patients with metastatic renal cell carcinoma receiving second‐line treatment with tyrosine kinase inhibitor following first‐line immune‐oncology …

International Journal of Urology

2024/1/19

MP16-10 SAFETY AND EFFICACY OF INTENSIVE INSTILLATION OF LOW-DOSE PIRARUBICIN VS. BACILLUS CALMETTE-GUÉRIN IN HIGH-RISK NON-MUSCLE-INVASIVE BLADDER CANCER

The Journal of Urology

2024/5

Hiroyuki Ito
Hiroyuki Ito

H-Index: 24

Shingo Hatakeyama
Shingo Hatakeyama

H-Index: 25

MP53-20 ASSOCIATION BETWEEN CUTANEOUS REACTIONS RELATED TO ENFORTUMAB VEDOTIN AND SERUM ALBUMIN LEVELS IN PATIENTS WITH ADVANCED UROTHELIAL CANCER

The Journal of Urology

2024/5

Shingo Hatakeyama
Shingo Hatakeyama

H-Index: 25

See List of Professors in Shingo Hatakeyama University(Hirosaki University)

Co-Authors

academic-engine